Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,350 | 4 | 88.4% |
| Food and Beverage | $308.75 | 3 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $2,350 | 4 | $0 (2023) |
| Miach Orthopaedics, Inc. | $161.34 | 1 | $0 (2024) |
| IBSA Pharma Inc. | $109.46 | 1 | $0 (2023) |
| MERZ NORTH AMERICA, INC. | $37.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $161.34 | 1 | Miach Orthopaedics, Inc. ($161.34) |
| 2023 | $809.46 | 2 | Merck Sharp & Dohme LLC ($700.00) |
| 2022 | $700.00 | 1 | Merck Sharp & Dohme LLC ($700.00) |
| 2021 | $950.00 | 2 | Merck Sharp & Dohme Corporation ($950.00) |
| 2017 | $37.95 | 1 | MERZ NORTH AMERICA, INC. ($37.95) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Miach Orthopaedics, Inc. | — | Food and Beverage | Cash or cash equivalent | $161.34 | General |
| 11/16/2023 | IBSA Pharma Inc. | Licart (Drug) | Food and Beverage | In-kind items and services | $109.46 | General |
| Category: non-opioid analgesic | ||||||
| 01/30/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 01/26/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 08/04/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 02/03/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 01/30/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $37.95 | General |
| Category: Musculoskeletal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 738 | 1,145 | $1.3M | $125,653 |
| 2022 | 13 | 469 | 703 | $757,245 | $90,146 |
| 2021 | 17 | 594 | 807 | $1.1M | $114,902 |
| 2020 | 13 | 408 | 582 | $618,721 | $82,127 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 425 | $233,750 | $47,619 | 20.4% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 18 | 41 | $91,020 | $16,624 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $80,757 | $11,682 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 133 | $49,875 | $10,308 | 20.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 42 | 64 | $82,125 | $6,770 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $30,240 | $5,177 | 17.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 23 | 33 | $148,849 | $3,899 | 2.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 32 | 39 | $119,475 | $3,554 | 3.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 21 | $15,645 | $3,465 | 22.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 23 | 28 | $110,563 | $3,075 | 2.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 11 | 12 | $99,433 | $2,997 | 3.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 24 | $12,756 | $2,808 | 22.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 19 | 29 | $51,786 | $1,975 | 3.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 18 | 28 | $24,887 | $1,502 | 6.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 16 | $7,794 | $1,338 | 17.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 11 | 11 | $32,102 | $1,069 | 3.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 11 | 13 | $42,053 | $946.01 | 2.2% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 13 | 16 | $26,565 | $780.95 | 2.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 77 | $4,620 | $64.93 | 1.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 293 | $161,150 | $33,702 | 20.9% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2022 | 19 | 36 | $79,920 | $23,005 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $49,850 | $7,567 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 76 | $28,500 | $6,085 | 21.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 31 | 52 | $69,750 | $5,723 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $18,480 | $3,219 | 17.4% |
About Dr. Salvador Portugal, D.O
Dr. Salvador Portugal, D.O is a Physical Medicine & Rehabilitation healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1114189727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Salvador Portugal, D.O has received a total of $2,659 in payments from pharmaceutical and medical device companies, with $161.34 received in 2024. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($2,350).
As a Medicare-enrolled provider, Portugal has provided services to 2,209 Medicare beneficiaries, totaling 3,237 services with total Medicare billing of $412,827. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation
- Location New York, NY
- Active Since 06/26/2008
- Last Updated 03/26/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1114189727
Products in Payments
- Licart (Drug) $109.46
- Xeomin (Biological) $37.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in New York
Heidi Fusco, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $160,307
Dr. Kimberly Sackheim, Do, DO
Physical Medicine & Rehabilitation — Payments: $158,974
Michael O'dell, Md, MD
Physical Medicine & Rehabilitation — Payments: $103,549
Dr. Craig Antell, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $78,788
Russell Silver, Md, MD
Physical Medicine & Rehabilitation — Payments: $66,937
Ehsan Abdeshahian, Md, MD
Physical Medicine & Rehabilitation — Payments: $54,837